Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
US9233931B2 · kind B2 · utility
3Cited by
8References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 4, 2013 |
| Grant date | Jan 12, 2016 |
| Priority date | — |
| Expiry date | Nov 12, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of one of the formulas I to XXI; a pharmaceutical composition comprising at least one such compound; and the use of at least one such compound in preparing a drug to treat, in a subject, a genetic disease resulting from at least one splicing anomaly.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.